These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 932490)

  • 1. Clearance of gentamicin during hemodialysis: comparison of four artificial kidneys.
    Halpren BA; Axline SG; Coplon NS; Brown DM
    J Infect Dis; 1976 Jun; 133(6):627-36. PubMed ID: 932490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity in gentamicin clearance between high-efficiency hemodialyzers.
    Agarwal R; Cronin RE
    Am J Kidney Dis; 1994 Jan; 23(1):47-51. PubMed ID: 8285197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gentamicin clearance during hemodialysis: a comparison of high-efficiency cuprammonium rayon and conventional cellulose ester hemodialyzers.
    Agarwal R; Toto RD
    Am J Kidney Dis; 1993 Aug; 22(2):296-9. PubMed ID: 8352256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of dual dialyzers in parallel and series to improve urea clearance in large hemodialysis patients.
    Fritz BA; Doss S; McCann LM; Wrone EM
    Am J Kidney Dis; 2003 May; 41(5):1008-15. PubMed ID: 12722035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodialysis elimination rates and clearance of gentamicin and tobramycin.
    Matzke GR; Halstenson CE; Keane WF
    Antimicrob Agents Chemother; 1984 Jan; 25(1):128-30. PubMed ID: 6703676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of gentamicin during peritoneal dialysis in children.
    Jusko WJ; Baliah T; Kim KH; Gerbracht LM; Yaffe SJ
    Kidney Int; 1976 May; 9(5):430-8. PubMed ID: 940277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tobramycin and gentamicin concentrations in the serum of normal and anephric patients.
    Lockwood WR; Bower JD
    Antimicrob Agents Chemother; 1973 Jan; 3(1):125-9. PubMed ID: 4790568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reasonably short hemodialysis time can be achieved without ultra-high efficiency dialyzers and without ultrafiltration-controlled delivery systems.
    Galen M
    ASAIO Trans; 1989; 35(3):255-7. PubMed ID: 2597458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of standard Kiil and pyramid-surface dialyzers.
    Yager H; Richardson JA
    JAMA; 1972 May; 220(8):1101-3. PubMed ID: 5067511
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization of gentamicin pharmacokinetics in patients hemodialyzed with high-flux polysulfone membranes.
    Amin NB; Padhi ID; Touchette MA; Patel RV; Dunfee TP; Anandan JV
    Am J Kidney Dis; 1999 Aug; 34(2):222-7. PubMed ID: 10430966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of hemodialysis on gentamicin pharmacokinetics, removal during hemodialysis, and recommended dosing.
    Sowinski KM; Magner SJ; Lucksiri A; Scott MK; Hamburger RJ; Mueller BA
    Clin J Am Soc Nephrol; 2008 Mar; 3(2):355-61. PubMed ID: 18235142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of serum gentamicin concentrations in patients undergoing hemodialysis.
    Goetz DR; Pancorbo S; Hoag S; Bloom P
    Am J Hosp Pharm; 1980 Aug; 37(8):1077-83. PubMed ID: 7405935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Determination of clearance for urea-controlled hemodialysis].
    Ahrenholz P; Holtz M; Falkenhagen D; Klinkmann H
    Z Urol Nephrol; 1988 Jul; 81(7):455-66. PubMed ID: 3176721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dialyzer clearances and mass transfer-area coefficients for small solutes at low dialysate flow rates.
    Leypoldt JK; Kamerath CD; Gilson JF; Friederichs G
    ASAIO J; 2006; 52(4):404-9. PubMed ID: 16883120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clearance calculations in hemodialysis: application to blood, plasma, and dialysate measurements for ethambutol.
    Lee CS; Marbury TC; Benet LZ
    J Pharmacokinet Biopharm; 1980 Feb; 8(1):69-81. PubMed ID: 7381692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gentamicin pharmacokinetics during slow daily home hemodialysis.
    Manley HJ; Bailie GR; McClaran ML; Bender WL
    Kidney Int; 2003 Mar; 63(3):1072-8. PubMed ID: 12631090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosing of gentamicin in patients with end-stage renal disease receiving hemodialysis.
    Teigen MM; Duffull S; Dang L; Johnson DW
    J Clin Pharmacol; 2006 Nov; 46(11):1259-67. PubMed ID: 17050791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing dialysate flow rate increases dialyzer urea clearance and dialysis efficiency: an in vivo study.
    Azar AT
    Saudi J Kidney Dis Transpl; 2009 Nov; 20(6):1023-9. PubMed ID: 19861865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Gambro Lundia Major 1.36 m2 disposable parallel plate dialyzer.
    Dziukas LJ; Douglas SM; Carter PM; Campbell DC; Andrews JT; d'Apice AJ; Kincaid-Smith P
    J Dial; 1979; 3(4):309-25. PubMed ID: 263953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of netilmicin during hemodialysis: comparison of four artificial kidneys.
    Herrero A; Rius Alarcó F; García-Díez JM; Mahiques E; Domingo JV
    Int J Clin Pharmacol Ther Toxicol; 1988 Dec; 26(12):605-9. PubMed ID: 3209278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.